Status:
COMPLETED
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Healthy
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
Context: Oral formulations of GLP-1 and PYY3-36, two satiety peptides, were studied. An oral delivery system would be preferable in many of the possible therapeutic indications of these peptides. Obj...
Detailed Description
The study was conducted as a phase I, open, placebo-controlled, dose-escalating study. In part I, six treatments, separated by at least 7 days, were performed in 6 male subjects; treatments consisted ...
Eligibility Criteria
Inclusion
- healthy males
Exclusion
- females
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00468884
Start Date
October 1 2006
End Date
February 1 2007
Last Update
October 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Centre, University Hospital
Basel, Switzerland, CH-4031